Haplotype-based association of regulator of G-protein signaling 5 gene polymorphisms with essential hypertension and metabolic parameters in Chinese

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 12, 2009, Pages 1483-1488

  Xiao, Bing ^a,b   Zhang, Yi ^a,b,e   Niu, Wen Quan ^a,b   Gao, Pin Jing ^a,b,c,d   Zhu, Ding Liang ^a,b,c,e  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Hypertension   (China)

^c Shanghai Key Laboratory of Chemical Biology   (China)

^d Chinese Academy of Sciences   (China)

^e Sino French Research Center for Life Science and Genomics   (China)

Author keywords

Haplotypes; Hypertension; Polymorphism; RGS5

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE FREQUENCY; HAPLOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; REGULATOR OF G PROTEIN SIGNALING 5 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RGS PROTEINS;

EID: 73249129079     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.344     Document Type: Article

References (30)

1. Luft FC. Geneticism of essential hypertension. Hypertension 2004;43:1155-1159
2. Hollinger S, Hepler JR. Cellular regulation of RGS proteins. Modulators and integrators of G protein signaling. Pharmacol Rev 2002;54:527-559
3. Schieffer B, Drexler H, Ling BN, Marrero MB. G protein coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol 1997;272:C2019-30.
4. Wieland T, Mittmann C. Regulators of G-protein signaling: multifunctional proteins with impact on signaling in the cardiovascular system. Pharmacol Ther 2003;97:95-115.
5. Hao J, Michalek C, Zhang W, Zhu M, Xu X, Mende U. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation. J Mol Cell Cardiol 2006;41:51-61.
6. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH. Pericyte-specific expression of RGS5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J 2003;17:440-442
7. Li J, Adams LD, Wang X, Pabon L, Schwartz SM, Sane DC, et al. Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque. J Vasc Surg 2004;40:519-528
8. Wang X, Adams LD, Pabón LM, Mahoney WM Jr, Beaudry D, Gunaje J. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aor tic banding-induced hypertrophy. J Mol Cell Cardiol 2008;44:539-550
9. Chang YP, Liu X, Kim JD, Ikeda MA, Layton MR, Weder AB. Multiple genes for essential-hypertension susceptibility on chromosome1q. Am J Hum Genet 2007;80:253-264
10. Kirsch T, Wellner M, Luft FC, Haller H, Lippoldt A. Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res 2001;910: 106-115
11. Grayson TH, Ohms SJ, Brackenbury TD, Meaney KR, Peng K, Pittelkow YE, et al. Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets. BMC Genomics 2007;8:404.
12. Cho H, Park C, Hwang IY, Han SB, Schimel D, Despres D, et al. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 2008;28: 2590-2597
13. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-2470
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223
16. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98
17. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434
18. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
19. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. J Am Med Assoc 2007;297:489-498
20. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-397
21. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99
22. Perola M, Kainulainen K, Pajukanta P, Terwilliger JD, Hiekkalinna T, Ellonen P, et al. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens 2000;18:1579-1585
23. Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study Hypertension 2002;40:1-6.
24. James K, Weitzel LR, Engelman CD, Zerbe G, Norris JM. Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet 2003;4:S83.
25. DiPetrillo K, Tsaih SW, Sheehan S, Johns C, Kelmenson P, Gavras H, et al. Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice. Physiol Genomics 2004;17: 215-220
26. Stoll M, Kwitek-Black AE, Cowley AW Jr, Harris EL, Harrap SB, Krieger JE, et al. New target regions for human hypertension via comparative genomics. Genome Res 2000;10:473-482
27. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, et al. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 2001;71:70-77
28. Qi Y, Niu W, Zhou W, Hou S, Qiu C. Correlation between angiotensinogen gene polymorphisms and essential hypertension in Chinese population. J Hum Hypertens 2008;22:147-150
29. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-228
30. Lu X, Zhao W, Huang J, Li H, Yang W, Wang L, et al. Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study. Hum Genet 2007;121:327-335